NLVP
KPTI icon

New Leaf Venture Partners’s Karyopharm Therapeutics KPTI Stock Holding History

New Leaf Venture Partners’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,863
Closed -$1.5M – 15
2016
Q2 		$1.5M Buy
14,863
+14,048
+1,724% +$1.83M 1.29% 11
2016
Q1 		$109K Buy
+815
New +$90K 0.1% 13
2015
Q4 		– Sell
-2,732
Closed -$431K – 11
2015
Q3 		$431K Sell
2,732
-5,714
-68% -$1.53M 0.37% 13
2015
Q2 		$3.45M Hold
8,446
– – 2.28% 10
2015
Q1 		$3.88M Hold
8,446
– – 2.63% 10
2014
Q4 		$4.74M Buy
+8,446
New +$4.8M 2.31% 8

Other funds holding KPTI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New Leaf Venture Partners's KPTI Position: Q3 2016 in Review

New Leaf Venture Partners sold out of Karyopharm Therapeutics (KPTI) in Q3 2016, closing a stake of 14,863 shares — an estimated $1.5M sold.

New Leaf Venture Partners first reported a position in KPTI in Q4 2014 and held it in 6 quarters. The position peaked at $4.74M in Q4 2014. 79 funds tracked by Wall St. Rank hold KPTI as of Q3 2016.

  • New Leaf Venture Partners reported no remaining Karyopharm Therapeutics position as of Q3 2016 after selling out during the quarter.
  • New Leaf Venture Partners sold 14,863 Karyopharm Therapeutics shares in Q3 2016, an estimated $1.5M.
  • New Leaf Venture Partners first reported a position in Karyopharm Therapeutics in Q4 2014 and held it in 6 quarters.
  • New Leaf Venture Partners's Karyopharm Therapeutics position peaked at $4.74M in Q4 2014.
  • 79 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2016.

Based on New Leaf Venture Partners's 13F filing for Q3 2016, filed 14 Nov 2016.